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Abstract. Motivation: HIV is difficult to treat because its virus mutates
at a high rate and mutated viruses easily develop resistance to existing drugs.
If the relationships between mutations and drug resistances can be determined
from historical data, patients can be provided personalized treatment accord-
ing to their own mutation information. The HIV Drug Resistance Database
was built to investigate the relationships. Our goal is to build a model using
data in this database, which simultaneously predicts the resistance of multiple
drugs using mutation information from sequences of viruses for any new pa-
tient.
Results: We propose two variations of a stacking algorithm which borrow in-
formation among multiple prediction tasks to improve multivariate prediction
performance. The most attractive feature of our proposed methods is the flex-
ibility with which complex multivariate prediction models can be constructed
using any univariate prediction models. Using cross-validation studies, we
show that our proposed methods outperform other popular multivariate pre-
diction methods.
Availability: An R package will be made available.
1. Introduction
HIV is difficult to treat because its virus mutates at a high rate and mutated
viruses easily develop resistance to existing drugs. Ideally, an HIV patient should
receive personalized treatment which is adapted to the mutation information of the
patient’s virus. If the relationships between mutations and drug resistances can be
determined from historical data, patients can be provided personalized treatment
according to their own mutation information. By consistently monitoring virus
mutations of patients, physicians can actively change their drugs to achieve the most
efficacious treatment. The HIV Drug Resistance Database was built to investigate
the relationships between HIV-1 protease and reverse transcriptase mutations to in
vitro resistance to multiple antiretroviral drugs [14]. The current database contains
sequences of about 5000 HIV isolates (i.e. viruses taken from 5000 infected patients)
and their resistance to 18 HIV drugs in three classes. The information for 240
possible HIV drug resistant mutations can be extracted from the sequences of each
isolate, which are used as candidate biomarkers for predicting drug resistance. The
drug resistance is measured as the ratio of IC50 (the 50% inhibitory concentration
of a drug) of an isolate to the IC50 of a control [3]. Some thresholds of IC50 ratios
are selected by biologists to define resistance versus susceptibility to a drug [11].
The first analysis of this HIV database [11] compared 5 different models, in-
cluding least squares regression, support vector regression, least angle regression
(LARS), decision tree and neural network. None of these methods consistently
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outshone the others, but LARS [4] often performed better than the others. In this
analysis every drug resistance response was predicted separately without borrowing
information across the other drugs, even though these drugs are related with com-
mon features and they are predicted using the same mutation information. The first
analysis that borrows strength across multiple prediction tasks was conducted by
Heider et al [6]. The classification chain (CC) algorithm can improve classification
performance over individual models, and the ensemble classification chain (ECC)
can make further improvements over CC. The CC algorithm, originally proposed
by Read et al [10], predicts drug resistances one by one as a chain. The resistance of
a drug is predicted from not only the mutation information, but also the predicted
resistance of the other drugs with positions before the current drug in the chain.
Since the order of drugs in the chain may affect the prediction performance of CC,
another algorithm called ECC uses 10 different CCs of randomly ordered drugs,
and the final prediction is made using voting.
In genomic studies, researchers are often interested in multivariate outcomes, as
in this HIV example, motivating our investigation of algorithms that simultaneously
predict multiple outcomes from a common set of predictors. In the literature, there
are three major classes of multivariate outcome prediction methods. They are
neural networks, multivariate outcome models extended from their corresponding
univariate outcome models and stacking algorithms.
The literature about multivariate outcome learning is mostly based on neural
network models, which allow multiple prediction tasks to borrow information from
each other via the common hidden layers. The extension from univariate outcome
neural networks to their multivariate outcome versions is trivial, since it simply
requires the addition of more units in the output layer of the network. Many
researchers have shown that multivariate outcome learners outperform individual
learners of the same class [1], [15], [13]. Neural network models are examples of
deep learning algorithms, which have been successfully applied in many areas with
large data sets [7]. In a neural network, every neuron/unit is a simple model such
as logistic regression model, which quickly processes input from the previous layer
into input of the next layer of the network. A neural network is a network of many
such neurons, which consists of many unknown weights/parameters to be learned
or estimated from data. The performance of a neural network is heavily affected
by its settings, that is the number of hidden layers and the number of neurons in
each hidden layer. Genomic studies usually feature many predictors (e.g. genes)
and small or medium sample sizes. With a limited sample size, it is not practical
to build a deep neural network with many parameters to learn. It was shown
that univariate outcome LARS often provides better prediction performance than
univariate outcome neural networks for an HIV database [11]. In this paper, we
compare the performance of the multivariate outcome version of a neural network
with our proposed methods.
Some specific univariate outcome models have been extended to their multivari-
ate outcome versions, for example, elastic net for the case of multivariate normal
outcomes [16]. Incorporating multivariate normal outcomes requires the estima-
tion of their variance/covariance matrix. In high dimensional outcome data, such
models contain a large number of model parameters which require estimation, or
stronger model assumptions and/or sparse algorithms to reduce the number of
model parameters. The largest limitation of applying such approaches to solve real
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problems is that not many univariate outcome models are easily extended to their
multivariate outcome versions. For example, even the modeling of the correlation
structure among multivariate binary variables is not trivial. Elastic net variable
selection techniques using multivariate binary variables as outcomes is a complex
problem and incorporating mixed outcome types, e.g. binary and continuous, can
make the problem even more difficult to solve. Here, we consider a more general
approach to practically model multivariate outcome data, called stacking.
Stacking is an ensemble machine learning algorithm, which was developed for
univariate outcome prediction problems. Stacking first trains multiple learning al-
gorithms to predict the same univariate outcome, and then it trains a combiner
algorithm to integrate information from the step one predictions and re-predict the
final outcome. Stacking often yields better performance than all single models fit-
ted in step one [17]. The stacking algorithm was extended to handle multivariate
outcome prediction problems, and applied to music tags annotation [9]. The au-
thors suggest combining the predictions of multiple tasks instead of the traditional
approach of combining predictions of the same univariate outcome from multiple
algorithms, and showed it works better than fitting individual prediction tasks sep-
arately. In this paper, we use Standard Stacking (SS) to refer to this extended
version for multivariate outcome predictions.
In this paper, we propose two variations of stacking algorithms and their combi-
nation, which improves the prediction performance over the standard stacking ap-
proach under certain conditions. Using cross-validation studies on real data from
the HIV database, we compare prediction performance of our proposed revised
stacking algorithms with methods discussed above, including univariate outcome
LARS, classification chain and ECC, multivariate outcome neural network, and
multivariate outcome elastic net (for continuous outcomes only). The results of the
cross-validation study show our method outperforms all these methods.
2. Methods
Assume Y = (Y1, . . . ,YK) is an N × K data matrix of K outcome variables,
X = (X1, . . . ,XP ) is an N × P matrix of P predictor variables and N is the
sample size. For the HIV data set, Y is composed of IC50 ratios of K drugs for
the continuous outcome problem and indicators of resistance to K drugs for the
binary outcome problem. X is the mutation information of viruses, and P is the
total number of mutations in the sequence of one single virus. We are interested in
building a prediction model using data (X,Y ), so that we can predict resistance
of all K drugs Y˜new (IC50 ratio) or p˜new (probability of binary indicator), from
P observed mutations of the virus for a new patient Xnew.
We first describe the standard stacking algorithm, and then propose variations
of standard stacking. The proposed cross-validation stacking (CVS) and residual
stacking (RS) address shortcomings of standard stacking algorithms. These two
variations can be used together as cross-validation residual stacking (CVRS).
2.1. Standard stacking (SS). Algorithm 1 describes the standard stacking algo-
rithm for multivariate outcome problems proposed in [9]. The algorithm consists
of two steps of model fitting. In Step 1, the individual models are fitted to pre-
dict resistance of each drug separately. In Step 2, the combiner models are fitted
to integrate information from predictions of individual models and to make final
predictions of drug resistances. Finally, the drug resistances of a new virus are
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Algorithm 1 Standard Stacking (SS) for continuous outcomes
Input:
The matrices of mutations X and drug resistances Y = (Y1, . . . ,YK)
Xnew, the mutation information of a new virus
Algorithm:
[Step 1: Individual models] Learn f1k for the intermediate prediction of the k-th
drug, using predictors X and outcome Yk, for k = 1, . . . ,K
[Calculate fitted values] Yˆk = f1k(X) and Yˆ = (Yˆ1, . . . , YˆK)
[Step 2: Combiner models] Learn combiner models f2k for the final prediction of
the k-th drug, using predictors Yˆ and outcome Yk
[Final predictions] Predict resistance of all drugs from mutation data of a new
virus Xnew, for k = 1, . . . ,K
Y˜k,new = f2k (f11(Xnew), . . . , f1K(Xnew)) .(1)
Output:
The prediction models (f1k, f2k) for k = 1, . . . ,K;
Y˜new, the predicted resistance of all K drugs for the new virus.
predicted using models learned from the first two steps as well as mutation infor-
mation of the new virus. The SS algorithm is expected to outperform individual
models learned in Step 1, since Step 2 allows multiple prediction tasks to share
information.
Stacking is an algorithm that can use any univariate outcome methods as Indi-
vidual models in Step 1, and expect to improve their prediction performance via
the Combiner models in Step 2.
2.2. Cross-Validation Stacking (CVS), a variation of step 1. In Algorithm 1,
the combiner models are learned from the Step 1 ‘fitted’ values Yˆk = f1k(X), but in
formula (1), the final predictions are calculated from the Step 1 ‘predicted’ values
f1k(Xnew). The two types of quantities are different because X is used to learn the
f1k’s, but Xnew is independent of the f1k’s. In linear regression models, it is known
that predicted values have larger variance than fitted values. This discrepancy could
affect the performance of stacking predictions.
To accommodate the extra variation of prediction, we replace Yˆ in Algorithm 1
by the cross-validation predicted values Yˆ ∗. To obtain Yˆ ∗, we randomly partition
the data into M subsets. For every subset (X[m],Y[m]), we fit Step 1 models using
all data outside of this subset, denoted as (X[−m],Y[−m]). Using the predictor data
X[m] as new data in models fitted outside of subset m, we obtain predicted out-
comes, Yˆ ∗[m]. Combining predictions from all subsets, we obtain predicted values,
denoted as Yˆ ∗. Note there are M models learned for each drug in Step 1, but
the final prediction only allows one output, so we use the average of outputs (Yˆ ∗
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Algorithm 2 Cross-Validation Stacking (CVS) for continuous outcomes
Input:
The matrices of mutations X and drug resistances Y = (Y1, . . . ,YK)
Xnew, the mutation information of a new virus
Algorithm:
[Partition] Randomly partition data into M folds. Let (X [m],Y [m]) and
(X [−m],Y [−m]) be the data inside and outside of the m-th fold
for m = 1 to M do
[Step 1: Individual models] Learn f
[m]
1k for the intermediate prediction, using
predictors X [−m] and outcome Y [−m]k , for all k’s
[Calculate cross-validation predicted values]
Yˆ
∗[m]
k = f
[m]
1k (X
[m]) and Yˆ ∗[m] = (Yˆ ∗[m]1 , . . . , Yˆ
∗[m]
K )
end for
[Combine the results from M folds]
Yˆ ∗ = (Yˆ ∗[1]T , . . . , Yˆ ∗[M ]T )T and f1k = (f
[1]
1k + . . . + f
[M ]
1k )/M
[Step 2: Combiner models] Learn f2k for the final prediction of the k-th drug,
using predictors Yˆ ∗ and outcome Yk, for k = 1, . . . ,K
[Final predictions] Predict resistance from mutation data of a new virus
Y˜k,new = f2k (f11(Xnew), . . . , f1K(Xnew)) for k = 1, . . . ,K.
Output:
The prediction models (f1k, f2k) for k = 1, . . . ,K;
Y˜new, the predicted resistance of all K drugs for the new virus.
for continuous outcomes, and pˆ∗ for binary outcomes) from all M models in for-
mula (1). We name this algorithm Cross-Validation Stacking (CVS), since Yˆ ∗ are
cross-validation predictions. The detailed algorithm is described in Algorithm 2.
2.3. Residual Stacking (RS), a variation of step 2. In the standard stacking
algorithm, the Step 1 models learn the relationship between the predictors and
every individual outcome, while the Step 2 models use the relationship among
outcome variables to revise the Step 1 predictions. In the case where Step 2 models
are ordinary linear regressions, stacking produces weighted averages of the Step 1
predictions as final predictions. To predict the k-th outcome, the stacking algorithm
revises the Step 1 contribution of Yˆk from 100% to a new weight learned from the
Step 2 combiner models. Sometimes Step 1 already provides accurate predictions,
but the results of Step 2 models are not accurate due to data noise or unstable model
fitting, hence the Step 1 prediction accuracy may be compromised by stacking. This
argument can also be extended to stacking algorithms using other Step 2 models.
To ameliorate the problem above, we retain all information learned from the Step
1 models, and use the relationship among the outcomes to explain the variation that
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Algorithm 3 Residual Stacking (RS) for continuous outcomes
Input:
The matrices of mutations X and drug resistances Y = (Y1, . . . ,YK)
Xnew, the mutation information of a new virus
Algorithm:
[Step 1: Individual models] Learn f1k for the intermediate predictions, using
predictors X and outcome Yk, for all k = 1, . . . ,K
[Calculate fitted values] Yˆk = f1k(X) and Yˆ = (Yˆ1, . . . , YˆK)
[Calculate residuals] rk = Yk − Yˆk.
[Step 2: Combiner models] Learn combiner models g2k for the final prediction
of the k-th drug, using predictors (Yˆ1, . . . , Yˆk−1, Yˆk+1, . . . , YˆK) and outcome rk,
for k = 1, . . . ,K
[Final predictions] Predict resistance of all drugs for a new patient.
Yˆk,new = f1k(Xnew)
r˜k,new = g2k
(
Yˆ1,new, . . . , Yˆk−1,new, Yˆk+1,new, . . . , YˆK,new
)
Y˜k,new = f1k(Xnew) + r˜k,new(2)
Output:
The prediction models (f1k, g2k) for k = 1, . . . ,K;
Y˜new, the predicted resistance of all K drugs for the new virus.
cannot be explained by the Step 1 models. We call this revised stacking algorithm
Residual Stacking (RS), and provide the steps in Algorithm 3. In RS algorithm,
the Step 2 model g2k for the k-th outcome is learned using the Step 1 residual
rk as outcome, and using the Step 1 fitted value excluding Yˆk as predictors. The
formulas for the final predictions are revised using the residuals, which are given in
formula (2).
2.4. Stacking algorithms for binary outcomes. For binary outcomes, Yik, we
denote the predicted probability of the k-th outcome for the i-th sample in the
Step 1 model as pˆik = P (Yik = 1). Algorithms 1 and 2 can accommodate binary
outcomes simply by replacing Yˆ with pˆ. Algorithm 3, residual stacking, requires
additional changes to handle binary regression residual types. Instead of raw resid-
uals rk = Yk−pˆk, two alternative types of residuals are more appropriate for binary
outcomes. We consider Pearson Residual Stacking (PRS) and Deviance Residual
Stacking (DRS), which are described below.
The Pearson residual is defined as
rik = (Yik − pˆik)/
√
pˆik(1− pˆik),
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and the prediction formula (2) becomes
P (Y˜ik,new = 1) = r˜ik,new
√
pˆik,new(1− pˆik,new) + pˆik,new.
The Deviance residual is defined as
rik =
{√−2 log(pˆik) if Yik = 1
−√−2 log(1− pˆik) if Yik = 0.(3)
Formula (3) cannot be inverted explicitly to derive Y˜ik,new. Instead, we predict
P (Yik,new = 1) using the distance between the Step 2 predicted residuals r˜ik,new
and the two conditional residuals calculated using formula (3) and the Step 1 pre-
dicted probabilities pˆik,new. The prediction formula (2) becomes the proportion of
the inverted distance,
P (Y˜ik,new = 1) = d
−1
1 /(d
−1
1 + d
−1
0 ),
d1 =
∣∣∣∣r˜ik,new −√−2 log(pˆik,new)∣∣∣∣ ,
d0 =
∣∣∣∣r˜ik,new +√−2 log(1− pˆik,new)∣∣∣∣ .
Note that predicted probabilities using deviance residuals are guaranteed to be
in the range of [0, 1], but this is not true for the Pearson residual. For Pearson
residuals, we truncate the predicted probability onto the range [0, 1] when necessary.
2.5. Comparison of prediction performance of methods. Data
Following both [6] and [11], we compare the performance of the methods using
cross-validation on the real HIV data. Cross-validation is a popular alternative
to simulation studies for the comparison of methods, especially in the community
of machine learning researchers [8]. When the true data generation mechanism is
unknown or too complex, it is preferable to evaluate the performance of methods
by cross-validation on real data.
In the HIV database, the resistance of five Nucleoside RT Inhibitor (NRTI) drugs
were used as multivariate outcomes by [6], including Lamivudine (3TC), Abacavir
(ABC), Zidovudine (AZT), Stavudine (D4T), Didanosine (DDI). We use the same
five drugs as multivariate outcomes in our study. At the time of our analysis,
the database contains 1498 samples, with the measurements of their resistance to
NRTI drugs and 240 mutation variables. The sample size is reduced to 1246 after
we remove samples with missing values. We removed 12 mutation variables, since
they do not contain enough variation (i.e. fewer than 10 samples are mutated in
these variables). The final outcome data Y is a matrix of size 1246 × 5, and the
predictor data X is a matrix of 1246 × 228 values.
The IC50 ratios are used as the outcomes of drug resistance to compare the
prediction performance of methods for continuous multivariate outcomes. HIV sci-
entists define threshold values to convert the IC50 ratio into categorical outcomes,
“susceptive”, “low resistance”, and “high resistance”. Following [6], we combine
“low resistance” and “high resistance” into one category, and use the binary out-
come to compare the classification performance of the methods. At the time of our
analysis, the HIV database website recommended cutoff values to convert IC50 ra-
tios to binary outcomes are 3TC= 3, ABC= 2, AZT= 3, D4T= 1.5, and DDI= 1.5.
Since the database is actively expanded by new data submissions from researchers,
8 LI XING 1, MARY LESPERANCE 1, AND XUEKUI ZHANG 1,∗
we provide a snapshot of the data used in this paper as supplementary material for
this paper.
Methods compared
In the analysis of [11], LARS performs better than the other methods, and we
use LARS as the base model in CC and the stacking algorithms. The models
compared are (i) univariate outcome LARS models (uLARS) fitted separately for
each outcome, (ii) Ensemble Classification Chain (ECC), with LARS as each model
in the chain. In [6], 10 CC’s of randomly ordered chains were built, and the most
frequently predicted outcomes were used as final predictions for the ECC method.
We follow the same procedure for binary multivariate classifications, and extend
their idea to predict continuous outcomes as the average predictions of 10 continuous
multivariate outcome prediction chains. (iii) Multivariate outcome neural network
(NNet), which has one hidden layer with 20 neurons, and 5 units on the outcome
layer corresponding to the 5 drugs to be predicted. This network structure has
4685 weights/parameters to be estimated from data. We also tried NNet with 5
neurons in the hidden layer, (i.e. 1175 weights/parameters), which has the same
network structure as stacking. The result of this network is much worse than using
20 neurons, so we did not include it in this paper. (iv) Stacking algorithms and
their variations. (v) The multivariate normal outcome LARS (mLARS), which is
only used for continuous multivariate outcome problems.
ECC: Ensemble Classification Chain
uLARS: Univariate LARS
mLARS: Multivariate LARS
NNet: Neural Network
SS: Standard Stacking
CVS: cross-validation Stacking
RS: Residual Stacking
CVRS: cross-validation + residual stacking
DRS: deviance residual stacking
CVDRS: cross-validation + deviance residual stacking
PRS: Pearson residual stacking
CVPRS: cross-validation + Pearson residual stacking
Table 1. Abbreviations for methods compared
For the stacking algorithms, we compare various models in combination with
standard stacking (SS), cross-validation stacking (CVS), residual stacking (RS),
and cross-validation + residual stacking (CVRS). LARS is used as the Step 1 model
in all stacking algorithms applied here. For Step 2 models, we compared linear
regression (for continuous outcomes), logistic regression (for binary outcomes), and
decision trees. For binary outcome RS, we also compared deviance residuals and
Pearson residuals. The methods compared and their abbreviations are listed in
Table 1.
The LARS models are fitted using the R package ‘glmnet’ [5]. Decision trees
are fitted using the recursive partition implementation in the R package ‘rpart’ [2].
The neural network models are fitted using the R package ‘nnet’ [12].
Evaluation criteria
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We use 5-fold cross-validation to compare the methods. One subset, in turn,
is held out and the remaining 4 subsets are used to fit models, and the model
predictions are made on the holdout subset. The 5-fold cross-validation predictions
Y˜ are compared against the observed outcome data Y to evaluate each method
we applied. The average mean squared error (MSE) across the 5 drugs is used as
comparison criteria for continuous outcome problems. Smaller MSE indicates better
prediction performance. For binary outcome predictions of drug resistance versus
susceptive, we consider two criteria, average accuracy and AUC statistics. Average
accuracy is the proportion of correctly classified samples, which is computed using
the cut-off predicted probability of 0.5 to predict the binary outcome for Y . The
AUC statistic is the area under ROC curve, and the predicted probabilities are
used directly to compute it. Larger accuracy or AUC indicates better classification
performance.
Since the results can be affected by how the data are randomly split into 5
cross-validation subsets, we repeat the comparison 100 times with different folds
generated using different random seeds.
3. Results
3.1. Comparison of continuous outcome methods. Comparison of all meth-
ods
Figure 1 shows average Mean Squared Errors (MSEs) of 5-fold cross-validation
predictions of all methods (except for neural network) compared in this paper. Each
box displays the distribution of prediction MSEs of a method over 100 different
random splits of data. The performance of the Neural networks is much worse
than all other models in our comparison and we exclude NNet from Figure 1 for
reasons of aesthetics. The same figure with NNet is in supplementary Figure 1.
The multivariate outcome neural network is the only method in the study that
is not based on LARS. In the analysis of [11], binary prediction performance of
univariate LARS is much better than univariate neural networks for the four drugs
we consider here, and slightly worse for the drug 3TC. The multivariate outcome
version of the neural network model does not outperform LARS in our study.
The methods with the best performance are RS and CVRS with regression trees
in the Step 2 models. It is not a surprise that the individual univariate LARS
performs worst among them, since uLARS does not borrow information across
multiple prediction tasks. RS and CVRS performance is considerably reduced if we
replace regression trees by linear regression in the Step 2 models. This is because
the relationships in Step 2 of RS or CVRS may contain strong interaction/nonlinear
effects. Figure 2 shows a sample residual stacking fitted Step 2 regression tree for
drug two. The second drug residual r˜2 is predicted by the interaction of the fifth
and first drugs (Yˆ5, Yˆ1) in the residual stacking tree. Adding this interaction term
to the linear regression model version of Step 2, results in a p-value of 2.2×10−16 for
the likelihood ratio test, suggesting that the interaction term significantly improves
model fit. In addition, prediction performance is reduced substantially if we replace
RS by SS or replace CVRS by CVS for the Step 2 tree models.
Evaluation of residual and cross-validation effects
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Figure 1. Boxplots of average Mean Squared Errors of 5 fold
cross-validation predictions for each method. Each box shows av-
erage MSEs from 100 replicates of random split cross-validation
folds. Gray, red, and green boxes represent non-stacking algo-
rithms, stacking algorithms using linear regression as Step 2 model,
and stacking algorithms using regression tree as Step 2 model, re-
spectively. Smaller MSE indicates better prediction performance.
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Figure 2. Example of fitted regression tree for Step 2 of residual
stacking for Drug 2.
In this paper we propose two variations of standard stacking, residual stacking
and cross-validation stacking. Next we evaluate whether our proposed variations
improve prediction performance over standard stacking.
Visual inspection of the boxplots in Figure 1 provides some information about the
relative performance of our proposed methods versus standard stacking, however,
a more powerful approach is to compare the 100 within-replicate differences of
average MSE’s for relevant pairs of methods. Figure 3 shows boxplots and paired
t-test p-values for pairs which evaluate the effect of our variations.
The top panel in Figure 3 compares RS versus SS and CVRS versus CVS, which
estimates the effect of the ‘residual’ method in the stacking algorithm. We found
that all stacking algorithms incorporating residuals have smaller median MSE’s
than their corresponding non-residual versions of the algorithms. The visual trend is
supported by significant p-values for the paired t-tests. This indicates that residual
stacking significantly improves prediction performance consistently in all settings
we considered.
The bottom panel in Figure 3 compares CVS versus SS and CVRS versus RS,
which estimates the effect of ‘cross-validation’ on stacking prediction performance.
CV stacking significantly reduces MSE’s over the non-CV version, only when the
Step 2 model is linear regression. In interpreting this result, we note that fitted
values have smaller variance than predicted values, which motivated us to propose
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Figure 3. Paired t-test for effect of residual and CV in stacking
algorithms. Each row represents differences of 100 pairs of MSEs.
The negative difference indicates that proposed CV or residual
stacking can improve the prediction performance in that setting.
the use of CVS. For Step 2 linear regression, all changes of predictor values will be
linearly passed to the final output. Hence CV stacking is helpful in this situation.
However, a regression tree is more robust to small errors, since each node of a
regression tree is a binary decision. Small changes of predictor values will not
affect the results of regression trees, as long as the changes do not pass the threshold
and cause change in the binary decision at the nodes. In fact, if all values of the
predictors are consistently scaled, the structure of the decision tree will not change,
only the threshold of each decision node will be scaled accordingly. This explains
why CV stacking is not helpful when the Step 2 model is regression tree.
3.2. Comparison of binary outcome classification methods. Comparison
of all methods Figure 4 shows the prediction performance of all methods we
evaluated, except the neural network. The left panel shows boxplots of accuracy, the
proportion of correct predictions, while the right panel shows boxplots of the Area
Under ROC curve (AUC) statistics. Each boxplot represents the distribution for
100 replicates of random split cross-validation folds. The Neural network is still the
worst performer, for both accuracy and AUC, among the models in our comparison
and it isn’t shown here. The same figure including NNet is in supplementary Figure
2.
In Figure 4, ECC and all stacking models show improved accuracy over the
individual univariate LARS model. The majority (8 of 12) of stacking models have
better accuracy than ECC with significant paired t-test p-values. The visual trends
of comparisons of AUC are consistent with the trends of accuracy, except the order
of stacking and ECC. For AUC, ECC is the second best model among all models
we compared. ECC is slightly worse than CVDRS that uses logistic regression as
the Step 2 combiner model, with a paired t-test p-value of 0.0919. This result
can be explained by the shared property of ensemble methods and AUC statistics.
Accuracy measures the prediction performance of one decision rule corresponding
to a specific threshold value, 0.5 here. AUC measures the weighted average of
prediction performance across multiple decision rules corresponding to all possible
threshold values. Each classification chain works well at some specific threshold
value. ECC makes decisions by voting of multiple CC’s, so it is not surprising
that ECC makes “smoothed” improvement across many different threshold values
of choice, hence shows better performance in terms of AUC.
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Figure 4. Comparison of performance of the binary classification
methods. Boxplots show accuracy (left panel) or AUC (right panel)
from 100 replicates of random splits of cross-validation folds. Gray,
red, and green boxes represent non-stacking algorithms, stacking
algorithms using linear regression as Step 2 model, and stacking
algorithms using regression trees as Step 2 model, respectively.
Larger AUC/accuracy indicates better prediction performance.
Evaluation of residual and cross-validation effects
Figure 5 evaluates the residual and cross-validation effects for the various stack-
ing algorithms. The left panel shows paired differences of accuracy, while the right
panel shows the paired differences of AUC statistics.
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Figure 5. Evaluation of residual and cross-validation effects for
the stacking algorithms. Boxplots and p-values of the paired dif-
ferences of Accuracy and AUC for various pairs of methods.
The top three panels in Figure 5 show results for the evaluation of residual effects.
Both deviance residual and Pearson residual stacking algorithms consistently show
larger accuracy and larger AUC than their corresponding non-residual versions.
The visual trend is supported by significant p-values of all paired t-tests. This
indicates that residual stacking consistently improves performance of multivariate
binary classification problems. We also found that the deviance residual is preferred
when the Step 2 model is logistic regression, and the Pearson residual is preferred
when the Step 2 model is a regression tree.
The bottom panel in Figure 5 shows results for the evaluation of cross-validation
effects. There are no strong visual trends to support that cross-validation can
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improve classification performance in most settings. This result is not surprising,
since small bias (between fitted probability and predicted probability in the Step 1
models) may not be large enough to pass threshold values and change final binary
decisions of classification. In addition, unlike continuous outcome problems, the
exact relationship between predicted probability and fitted probability is unclear.
The paired t-test p-values suggest significant AUC prediction improvement when
the Step 2 model is logistic regression. Unlike accuracy, AUC is an averaged sum-
mary of classification performance over all possible threshold values. When small
improvements in predicted probabilities can affect binary classifications based on
some (but not all) threshold values, the AUC will be affected. This result suggests
cross-validation stacking is preferred for classification problems, only if the Step
2 model is logistic regression and if the prediction problem requires soft decisions
(decisions based on multiple threshold values).
4. Discussion
The most attractive property of the stacking algorithm is its flexibility. Complex
multivariate outcome prediction models can be easily constructed using models for
univariate outcome prediction problems. The models used to construct stacking
algorithms can be any model of the user’s choice, from simple linear regressions to
very complex Bayesian hierarchical models.
Different models can be used in the same step, to handle mixed types of multi-
variate outcomes. For example, bivariate outcomes which contain a binary variable
(e.g. disease status) and a continuous variable (e.g. blood pressure)can be accom-
modated. In each step, a linear regression models could predict the blood pressure
and logistic regression could predict the binary disease status.
Stacking algorithms can be considered as revised versions of three-layer neural
networks, which can be more effective on smaller sample size problem where fitting
deep neural networks is not practical. Stacking is different from standard neural
networks in 3 ways. (1) Its hidden layer (Step 1 models) must have the same number
of neurons as the output layer (2) The learning of parameters of the hidden layer is
directly supervised by the observed outcome data, while standard neural networks
learn parameters in hidden layers indirectly supervised through their connection
to outcome data in the output layer. (3) Stacking algorithms can use complex
models in the neurons on a fixed network structure, which contains limited number
of model parameters to learn. In contrast, deep neural networks (DNN) build
complex network structures of many hidden layers and many neurons, but each
neuron is often a simple function. DNN usually has a large number of parameters
to learn from data. The difference between stacking algorithms and neural networks
makes stacking more suitable for data sets with smaller sample sizes. This explains
why neural networks do not show superior performance in our study.
The computational complexity of classification chains is similar to Step 1 models
of the stacking algorithms. Extra time used to fit Step 2 models makes stacking
slower than CC, but ECC needs to fit multiple CC models, which is slower than
stacking. In CC algorithms, predictor and outcome information are used equiv-
alently in a single model, while stacking algorithms use two separate models to
describe the two types of information. This difference makes stacking more flexible
14 LI XING 1, MARY LESPERANCE 1, AND XUEKUI ZHANG 1,∗
and more powerful when the relation between predictors and outcome and the re-
lation among outcomes are too different to be modelled by the same model. This
explains why in our study stacking algorithms often outperform ECC.
In the comparison, we found the performance rank of ECC is much higher when
using AUC as the comparison criteria. This suggests that ensemble algorithms are
helpful in applications where a hard binary decision is not required.
5. Conclusion
Based on results of this study, we recommend residual stacking algorithms.
Cross-validation stacking can be used together with residual stacking if the Step
2 models are linear models but not trees. This algorithm outperforms all other
algorithms that we considered in this study.
Any model can be used to construct a stacking algorithm. When a new model
is used to replace LARS or regression trees in our study, we suggest the use of the
cross-validation approach illustrated in this paper, to compare different models of
choice and compare combinations of residual stacking and cross-validation stacking.
This ensures that the best model is used in data analysis.
Acknowledgements
Authors thank Professor Dominik Heider (University of Marburg) for his helpful
discussion about pre-processing data from HIV data base.
Funding
This work was supported by the Natural Sciences and Engineering Research
Council Discovery Grants (XZ, ML), Natural Sciences and Engineering Research
Council Post Doctoral Fellowship (LX), and the Canada Research Chair (XZ).
References
[1] J Baxter. A Model of Inductive Bias Learning. Journal of Artificial Intelligence Research,
12:149–198, March 2000.
[2] Leo Breiman. Classification and Regression Trees. In Classification And Regression Trees.
Routledge, 1984.
[3] Dana S Clutter, Michael R Jordan, Silvia Bertagnolio, and Robert W Shafer. HIV-1 drug
resistance and resistance testing. Infection, Genetics and Evolution, 46:292–307, December
2016.
[4] B Efron, T Hastie, I Johnstone, and R Tibshirani. Least angle regression. The annals of
statistics, 32(2):407–451, April 2004.
[5] Jerome Friedman, Trevor Hastie, and Robert Tibshirani. Regularization Paths for Generalized
Linear Models via Coordinate Descent. Journal of Statistical Software, 33(1):1–22, 2010.
[6] Dominik Heider, Robin Senge, Weiwei Cheng, and Eyke Hu¨llermeier. Multilabel classification
for exploiting cross-resistance information in HIV-1 drug resistance prediction. Bioinformatics
(Oxford, England), 29(16):1946–1952, June 2013.
[7] Yann LeCun, Yoshua Bengio, and Geoffrey Hinton. Deep learning. Nature, 521(7553):436–
444, May 2015.
[8] F Leisch and E Dimitriadou URL http CRAN R-project org package mlbench. mlbench:
machine learning benchmark problems. R package version 2.1-1, 2010.
[9] Matt Pierce and George Tzanetakis. An Empirical Investigation of Stacking for Music Tag
Annotation. In 2011 10th International Conference on Machine Learning and Applications
and Workshops, pp. 90–95. IEEE, 2011.
[10] Jesse Read, Bernhard Pfahringer, Geoff Holmes, and Eibe Frank. Classifier chains for multi-
label classification. Machine Learning, 85(3):333–359, 2011.
SIMULTANEOUS PREDICTION OF MULTIPLE OUTCOMES USING REVISED STACKING ALGORITHMS15
[11] S Y Rhee, J Taylor, G Wadhera, A Ben-Hur, D L Brutlag, and R W Shafer. Genotypic pre-
dictors of human immunodeficiency virus type 1 drug resistance. Proceedings of the National
Academy of Sciences of the United States of America, 103(46):17355–17360, November 2006.
[12] Brian D Ripley. Pattern Recognition and Neural Networks. Cambridge University Press, 1996.
[13] S Thrun systems. Multitask Learning. Machine Learning, 28(1):41–75, 1997.
[14] Michele W Tang, Tommy F Liu, and Robert W Shafer. The HIVdb System for HIV-1 Geno-
typic Resistance Interpretation. Intervirology, 55(2):98–101, 2012.
[15] Sebastian Thrun. Is learning the n-th thing any easier than learning the first? Advances in
Neural Information Processing Systems, 8:640–646, 1996.
[16] Robert Tibshirani, Jacob Bien, Jerome Friedman, Trevor Hastie, Noah Simon, Jonathan
Taylor, and Ryan J Tibshirani. Strong rules for discarding predictors in lasso-type problems.
Journal of the Royal Statistical Society. Series B. Statistical Methodology, 74(2):245–266,
November 2011.
[17] David H Wolpert. Stacked generalization. Neural Networks, 5(2):241–259, January 1992.
1Department of Mathematics and Statistics, University of Victoria, Victoria, V8N
1Y2, Canada.
E-mail address: Xuekui@UVic.ca
